麝香保心丸对PCI术后患者炎症因子及血管内皮功能影响
Jiankang Qianyan(2019)
Abstract
目的:探讨麝香保心丸对冠心病(CHD)患者经皮冠状动脉介入治疗(PCI)术后血清血清亲环素A(CyPA)、sOX40L、超敏C-反应蛋白(hs-CRP)、一氧化氮(Nitric oxide NO)、血管活性肽内皮素-1(ET-1)水平影响.方法:拟行PCI术的160例冠心病患者随机分为对照组(80例)和观察组(80例).对照组患者给予常规治疗;观察组患者在对照组治疗的基础上于术前1周开始口服麝香保心丸(45mg,每日3次).观察两组患者手术前后血清CyPA、sOX40L、hs-CRP、NO、ET-1水平及不良反应发生情况.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined